Sbir topic 118: reagents for immunologic analysis of non-mammalian and underrepresented mammalian models.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00035
- Awardee
-
Qoolabs Inc. UEI K7HZKKAMVHK5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $600,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $600,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This total small business set-aside award was made under NAICS code 541712 as part of the Small Business Innovation Research Program Phase I. The work will take place in Carlsbad, California and aims to develop innovative solutions across over 125 topics focused on cancer treatment, infectious diseases, aging, and public health.
Quick answers
Who was awarded contract 75N93023C00035?
75N93023C00035 was awarded to Qoolabs Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2023.
How much is contract 75N93023C00035 worth?
The government has obligated $600,000 on 75N93023C00035.
Was contract 75N93023C00035 competed?
The extent of competition for 75N93023C00035 was full and open competition after exclusion of sources. The government received 13 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award